TY - JOUR
T1 - Towards Targeted Interventions in Low- And Middle-Income Countries
T2 - Risk Profiles of People Who Inject Drugs in Haiphong (Vietnam)
AU - Riondel, Adeline
AU - Huong, Duong Thi
AU - Michel, Laurent
AU - Peries, Marianne
AU - Oanh, Khuat Thi Hai
AU - Khue, Pham Minh
AU - Thanh, Nham Thi Tuyet
AU - Giang, Hoang Thi
AU - Vallo, Roselyne
AU - Cournil, Amandine
AU - Rapoud, Delphine
AU - Quillet, Catherine
AU - Laureillard, Didier
AU - Vinh, Vu Hai
AU - Moles, Jean Pierre
AU - Feelemyer, Jonathan
AU - Hammett, Ted
AU - Jarlais, Don Des
AU - Nagot, Nicolas
N1 - Publisher Copyright:
© 2020 Adeline Riondel et al.
PY - 2020
Y1 - 2020
N2 - People who inject drugs (PWID) are a dominant risk group afflicted by blood-borne viruses, mental health disorders, and social precariousness. Risk reduction interventions are administered to PWID regardless of their characteristics or specific risks. The objective of this cross-sectional analysis was to empirically identify profiles of PWID regarding their drug use, risk behaviors, and mental health in order to tailor adapted interventions taking into account limited access to comprehensive care in middle-income countries. PWID were recruited using respondent-driven sampling. PWID with urine testing positive for heroin or methamphetamine and manifesting recent skin injection marks were enrolled. Classification of participants was based on drug use, injection, risky sexual behavior, and mental health data. This was subjected to multiple correspondence analysis followed by hierarchical cluster analysis combined with K-means methodology. From October 2016 to January 2017, 1490 participants were recruited of which 1383 were eligible and enrolled. HCV prevalence was 70.5% and HIV prevalence 29.4%. The cluster analysis identified five distinct profiles: profile 1: recent injection practices and high alcohol consumption, profile 2: at-risk injection and sexual behaviors with precarious situations, profile 3: no sexual activity and older age, profile 4: frequent injections with high methamphetamine use, and profile 5: stable partnerships and less frequent injections. Our study has identified profiles of PWID at particularly high risks, and they should thus be targeted for interventions tailored to their specific risks.
AB - People who inject drugs (PWID) are a dominant risk group afflicted by blood-borne viruses, mental health disorders, and social precariousness. Risk reduction interventions are administered to PWID regardless of their characteristics or specific risks. The objective of this cross-sectional analysis was to empirically identify profiles of PWID regarding their drug use, risk behaviors, and mental health in order to tailor adapted interventions taking into account limited access to comprehensive care in middle-income countries. PWID were recruited using respondent-driven sampling. PWID with urine testing positive for heroin or methamphetamine and manifesting recent skin injection marks were enrolled. Classification of participants was based on drug use, injection, risky sexual behavior, and mental health data. This was subjected to multiple correspondence analysis followed by hierarchical cluster analysis combined with K-means methodology. From October 2016 to January 2017, 1490 participants were recruited of which 1383 were eligible and enrolled. HCV prevalence was 70.5% and HIV prevalence 29.4%. The cluster analysis identified five distinct profiles: profile 1: recent injection practices and high alcohol consumption, profile 2: at-risk injection and sexual behaviors with precarious situations, profile 3: no sexual activity and older age, profile 4: frequent injections with high methamphetamine use, and profile 5: stable partnerships and less frequent injections. Our study has identified profiles of PWID at particularly high risks, and they should thus be targeted for interventions tailored to their specific risks.
UR - http://www.scopus.com/inward/record.url?scp=85091598981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091598981&partnerID=8YFLogxK
U2 - 10.1155/2020/8037193
DO - 10.1155/2020/8037193
M3 - Article
C2 - 32964044
AN - SCOPUS:85091598981
SN - 2314-6133
VL - 2020
JO - BioMed Research International
JF - BioMed Research International
M1 - 8037193
ER -